Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiangsu Yike Food Group Co.,Ltd (301116.SZ)
Suqian, CN
Jiangsu Yike Food Group Co.,Ltd specializes in the slaughter and preparation of poultry, serving both the domestic Chinese market and international clientele. The company boasts an extensive and varied product line. This encompasses a broad selection of duck items, including diverse duck blood preparations (such as braised, frozen, hot pot, and duck blood tofu) and numerous duck parts like tongues, legs, feet, gizzards, necks, livers, and whole or half ducks, along with duck jerky, duck intestines, and assorted duck skewers. Their chicken offerings are equally comprehensive, featuring breasts, feet, boneless options, wing roots, and various chicken chops (e.g., star, whirlwind, snowflake, Sichuan), grilled wings, chicken skin skewers, and cumin drumsticks. Beyond poultry, their product assortment also extends to complementary food items. These include different tofu products (dried, skin, yuba), vegetables and fungi like kelp knots, enoki mushrooms, marinated shiitake, lotus root slices, and seaweed strips. Their selection is further enhanced by an array of other skewered items, such as Australian skewers, beef skewers, and grilled sausage slices. In addition to its core food processing operations, Jiangsu Yike Food Group Co.,Ltd is actively involved in upstream poultry industry activities. This includes the manufacturing and distribution of animal feed and poultry seedlings, alongside commodity hatching and the breeding of both poultry and specific poultry breeds. Established in 2004, the firm maintains its corporate headquarters in Suqian, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.74% | -4.81% | -13.87% | -16.23% | -22.00% | -13.08% | -14.80% | -37.25% | -73.33% | -73.33% | -73.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-07 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Farm Products: +8.2%-9.0% Q1'26: +9.5% (vs Q1'25)
-
EPS growth Agricultural Farm Products: +20.0%-381.8% Q1'26: +143.6% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Farm Products: +43.8%-2.4% Q1'26: -4.3% (vs Q1'25)
-
EBIT margin Agricultural Farm Products: +8.1%-1.1% Q1'26: +1.2% (vs Q1'25)
-
ROIC Agricultural Farm Products: +6.0%-7.8% Q1'26: +5.8% (vs Q1'25)
-
Share dilution Agricultural Farm Products: +0.0%-0.9% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Farm Products: 0.61×5.72× Q1'26: 11.51× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
20.84B
est: 26.18B (-20.4%)
|
18.96B
est: 21.53B (-11.9%)
|
22.44B
22.44B – 22.44B
+4.3% YoY
|
23.60B
23.60B – 23.60B
+5.1% YoY
|
| EBITDA |
592.97M
est: 498.84M (+18.9%)
|
259.03M
est: 410.15M (-36.8%)
|
427.58M
427.58M – 427.58M
+4.3% YoY
|
449.59M
449.59M – 449.59M
+5.1% YoY
|
| EBIT |
246.07M
est: 68.97M (+256.8%)
|
-216.11M
est: 56.71M (-481.1%)
|
59.12M
59.12M – 59.12M
+4.3% YoY
|
62.16M
62.16M – 62.16M
+5.1% YoY
|
| Net Income |
100.17M
est: 212.10M (-52.8%)
|
-279.79M
est: 49.64M (-663.6%)
|
85.74M
85.74M – 85.74M
+72.7% YoY
|
126.36M
126.36M – 126.36M
+47.4% YoY
|
| SGA |
470.28M
est: 414.93M (+13.3%)
|
85.45M
est: 341.15M (-75.0%)
|
355.65M
355.65M – 355.65M
+4.3% YoY
|
373.96M
373.96M – 373.96M
+5.1% YoY
|
| EPS |
0.22
est: 0.47 (-53.2%)
|
-0.62
est: 0.11 (-663.6%)
|
0.19
0.19 – 0.19
+72.7% YoY
|
0.28
0.28 – 0.28
+47.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 78.5K | 0.65% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hongru Chen | Board Secretary & Head of the Securities Affairs Center | — | male |
| Hongyong Chen | Accounting Supervisor, Chief Financial Officer, Deputy GM & Vice Chairman | — | male |
| Liyu Tian | Chairman & GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 301116.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
